Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

The conference highlighted new diagnostic tools, the role of genetics in hair loss, and emerging treatments.

Microneedling shows promise for hair loss but needs more research.

The document concludes that surgery is a preferred treatment for cicatricial alopecia, with the method chosen based on individual factors and may require multiple sessions and careful postoperative care.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

The refined wash test is a reliable way to measure daily hair loss and can tell the difference between different types of hair loss.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Women with diffuse hair loss often have lower iron and vitamin D levels, but their thyroid function is typically normal.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Hair restoration surgery can effectively treat hair loss in women.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

The new topical botanical formulation significantly regrew hair in all five patients without side effects.

PRP therapy is a safe and effective treatment for hair loss.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.